Comparison of the CHA 2 DS 2 -VASc, CHADS 2 , HAS-BLED, ORBIT, and ATRIA Risk Scores in Predicting Non–Vitamin K Antagonist Oral Anticoagulants-Associated Bleeding in Patients With Atrial Fibrillation-Reference-Cited by-同舟云学术

Comparison of the CHA 2 DS 2 -VASc, CHADS 2 , HAS-BLED, ORBIT, and ATRIA Risk Scores in Predicting Non–Vitamin K Antagonist Oral Anticoagulants-Associated Bleeding in Patients With Atrial Fibrillation

Published:2017-11 Issue:9 Volume:120 Page:1549-1556
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Yao Xiaoxi,Gersh Bernard J.,Sangaralingham Lindsey R.,Kent David M.,Shah Nilay D.,Abraham Neena S.,Noseworthy Peter A.^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey;Pisters;Chest,2010

2. A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study;Fang;J Am Coll Cardiol,2011

3. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation;O'Brien;Eur Heart J,2015

4. Scores to predict major bleeding risk during oral anticoagulation therapy: a prospective validation study;Donzé;Am J Med,2012

5. The risk stratification and stroke prevention therapy care gap in Canadian atrial fibrillation patients;Angaran;Can J Cardiol,2016

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS);European Heart Journal;2024-08-30

2. Brain MRI microbleeds and risk of intracranial hemorrhage in atrial fibrillation patients: A Swedish case-control study;Journal of Stroke and Cerebrovascular Diseases;2024-04

3. Intracardiac Echocardiography-guided Left Atrial Appendage Occlusion;Arrhythmia & Electrophysiology Review;2024-03-12

4. Lessons derived from post authorisation safety studies (ETNA-AF and XANTUS) on once daily direct oral anticoagulants for atrial fibrillation;International Journal of Cardiology;2024-03

5. Outcomes after TAVI in patients with atrial fibrillation and a history of recent PCI: Results from the ENVISAGE-TAVI AF trial;Clinical Research in Cardiology;2024-01-31